BRG.AU

33.74

-0.38%↓

SFR.AU

8.31

+2.21%↑

BRG.AU

33.74

-0.38%↓

SFR.AU

8.31

+2.21%↑

BRG.AU

33.74

-0.38%↓

SFR.AU

8.31

+2.21%↑

BRG.AU

33.74

-0.38%↓

SFR.AU

8.31

+2.21%↑

BRG.AU

33.74

-0.38%↓

SFR.AU

8.31

+2.21%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Closed

Sector Real estate

34.5 0.09

Overview

Share price change

24h

Current

Min

34.43

Max

34.63

Key metrics

By Trading Economics

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+1.05 upside

Dividends

By Dow Jones

Next Earnings

27 Nov 2024

Next Ex Dividend date

3 Dec 2024

Market Stats

By TradingEconomics

Market Cap

286M

20B

Previous open

34.41

Previous close

34.5

News Sentiment

By Acuity

47%

53%

25 / 160 Real estate

Fisher & Paykel Healthcare Corp Ltd Chart

Related News

28 Nov 2023, 21:34 UTC

Earnings

Fisher & Paykel Lifts 1st Half Profit 12% Amid Easing Freight Costs

2 Sept 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30 May 2024, 00:44 UTC

Market Talk
Earnings

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29 May 2024, 23:35 UTC

Market Talk

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28 May 2024, 22:43 UTC

Market Talk

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28 May 2024, 20:59 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28 May 2024, 20:58 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28 May 2024, 20:57 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28 May 2024, 20:56 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24 Apr 2024, 02:38 UTC

Market Talk

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

25 Mar 2024, 22:04 UTC

Market Talk

F&P Healthcare Can Meet Market Expectations for Revenue Growth -- Market Talk

29 Nov 2023, 02:47 UTC

Market Talk

Fisher & Paykel's Profit Guidance Looks Strong -- Market Talk

28 Nov 2023, 21:19 UTC

Earnings

Fisher & Paykel Lifts 1H Profit 12% Amid Easing Freight Costs

28 Nov 2023, 00:11 UTC

Market Talk

Fisher & Paykel's 2H Trends Key for Macquarie Analysts -- Market Talk

19 Sept 2023, 22:19 UTC

Market Talk

Fisher & Paykel's Gross Margin Recovery Will Take Time -- Market Talk

Peer Comparison

Price change

Fisher & Paykel Healthcare Corp Ltd Forecast

Price Target

By TipRanks

1.05% upside

12 Months Forecast

Average 35.043 AUD  1.05%

High 35.1 AUD

Low 35 AUD

Based on 4 Wall Street analysts offering 12 month price targets forFisher & Paykel Healthcare Corp Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

1

Buy

2

Hold

1

Sell

Sentiment

By Acuity

25 / 160 Real estate

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.